Assembly Biosciences
Swapnil Lad is a seasoned professional in clinical data management with extensive experience spanning over 19 years. Currently, Swapnil serves as Senior Director, CDM at Assembly Biosciences, Inc. since November 2019, having progressed through various roles including Director and Associate Director of Clinical Data Management. Prior to this, Swapnil worked at Cognizant Technology Solutions for over 11 years in multiple managerial positions, including Onsite-Service Delivery Manager and Team Manager in CDM. Earlier career experience includes serving as Senior Project Manager at Karmic Lifesciences Inc., and roles in marketing and business development at Ranbaxy and Nicholas Piramal India Pvt Ltd. Swapnil's educational qualifications include a Post Graduate Diploma in Clinical Research from the Academy for Clinical Excellence in Mumbai, along with a PGDBA in Marketing and HR from Symbiosis Institute of Management Studies, and a Bachelor of Pharmacy degree from Dr. D.Y. Patil Institute of Pharmacy.
This person is not in any teams
This person is not in any offices
Assembly Biosciences
9 followers
Assembly Biosciences (NASDAQ: ASMB) is a clinical-stage biotechnology company committed to bringing finite and curative therapies to the 270 million people living with hepatitis B virus (HBV) worldwide. A pioneer in the development of a new class of potent, oral core inhibitor drug candidates, Assembly Bio’s approach aims to break the complex viral replication cycle of HBV to free patients from a lifetime of therapy. Assembly Bio’s strategy toward cure includes a leading portfolio of more potent, next-generation core inhibitors, proof-of-concept combination studies and a research program focused on the discovery of novel HBV targets.